News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Katherine L. Ullman

Katherine L. Ullman is president, KLU Consulting, LLC

Articles by Katherine L. Ullman

Understanding Concomitant Components in Pharmaceutical Excipients. Image: monsitj - stock.adobe.com

Understanding Concomitant Components in Pharmaceutical Excipients

ByJennifer Putnam,Katherine L. Ullman,Priscilla Zawislak,David Schoneker,George Collins,Douglas G. Muse,Brian Carlin,Joseph Zeleznik,R. Christian Moreton

February 2nd 2021

Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.

Latest Updated Articles

Understanding Concomitant Components in Pharmaceutical Excipients
February 2nd 2021

Trending on Pharmaceutical Technology

Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet

Why the First Generic Single-Dose Flu Antiviral Approval Matters

Germany Pharma Tariff Threat: What Manufacturers Need to Know

PharmTech Weekly Roundup—June 19, 2026

Precision, Scale, and Compliance